title: [Registry of cardiac insufficiency in cardiology].
abstract: The epidemiological data on cardiac insufficiency in cardiology are very scarce. Therefore, with its members the National College of French Cardiologists has conducted a survey in order to evaluate the clinical, biological and therapeutic characteristics of cardiac insufficiency patients, and thus the possible seasonal variations, and to compare them to the current recommendations and to the data from a previous survey with the same methodology performed in 1994. During each season of the year 622 cardiologists recruited the first 5 cardiac insufficiency patients who had been stable for at least three months. 8618 observations were analysed. The results showed 68% are male with an average age of 70 years, with an ischaemic aetiology in 47% of cases, hypertensive in 23%, and in NYHA stage II or III in 94% of cases. The left ventricular ejection fractions are < 30% in 22% of cases, between 30 and 50% in 62% of cases, and > or = 50% in 16% of cases (20% in those over 78 years). Medical treatment includes diuretics in 78% of cases, with 28% of patients on spironolactone, angiotensin converting enzyme inhibitors (ACE inhibitors) in 82% of cases, betablockers in 29% of cases; ACE inhibitors and betablockers are clearly prescribed more often than during the previous 1994 survey but at doses often lower than the recommendations. Lastly, there are no seasonal variations in prescriptions.
authors.affiliation: CNCF Marseille, 4, avenue de Delphes, 13006 Marseille.
authors.forename: G
authors.initials: G
authors.lastname: Jullien
authors.forename: J Y
authors.initials: JY
authors.lastname: Fraboulet
authors.forename: P
authors.initials: P
authors.lastname: Poncelet
authors.forename: C
authors.initials: C
authors.lastname: Avierinos
authors.forename: A
authors.initials: A
authors.lastname: Sebaoun
authors.forename: H
authors.initials: H
authors.lastname: Gallois
authors.forename: A
authors.initials: A
authors.lastname: Cohen-Solal
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002309:Cardiology / Q000706:statistics & numerical data; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005602:France / Q000453:epidemiology; D006306:Health Surveys; D006333:Heart Failure / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D012042:Registries; D012621:Seasons; D012737:Sex Factors; D016277:Ventricular Function, Left
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics